No | Gender, age (years) | Association | Intervention(s) |
1 | Male, 2.3 | Methylmalonic acidaemia |
|
2 | Female, 12.6 | Gallstones |
|
3 | Male, 13 | Gallstones |
|
4 | Female, 13.7 | Pancreas divisum |
|
5 | Male, 14.1 | Sodium valproate |
|
6 | Male, 14.8 | Gallstones |
|
7 | Female, 8 | Choledochal cyst |
|
8 | Male, 4.9 | Idiopathic |
|
9 | Male, 10.3 | Trauma |
|
10 | Female, 13.5 | Gallstones |
|
11 | Male, 2 | Asparaginase |
|
12 | Female, 14.8 | Gallstones |
|
13 | Female, 13.5 | Gallstones |
|
14 | Male, 14.6 | Gallstones |
|
15 | Male, 5.5 | Choledochal cyst |
|
16 | Female, 12 | Viral infection |
|
17 | Male, 5.4 | Hereditary |
|
18 | Female, 12 | Idiopathic |
|
19 | Male, 14.7 | Gallstones |
|
20 | Male, 14.6 | Gallstones |
|
*Intervention during the follow-up period.
†Intervention at initial admission.
CBD, common bile duct; ERCP, endoscopic retrograde cholangiopancreatography.